SCHEMBL2289898

SCHEMBL2289898

COc1cc(O)cc(O)c1C(=O)C=CC=Cc1ccccc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.85
KMT2A Q03164 2/20 0.85
NPSR1 Q6W5P4 2/20 0.85
MEN1 O00255 1/20 0.85
KCNA3 P22001 1/20 0.85
TP53 P04637 1/20 0.70
CYP3A4 P08684 1/20 0.70
ATM Q13315 1/20 0.70
HSD17B10 Q99714 1/20 0.70
MAOB P27338 7/20 0.61
MAOA P21397 6/20 0.61
CYP19A1 P11511 1/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61
SLC5A1 P13866 2/20 0.61
SLC5A2 P31639 2/20 0.61
ABCG2 Q9UNQ0 2/20 0.57
NFKB1 P19838 1/20 0.57
DPP4 P27487 1/20 0.57
NFKB2 Q00653 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2289891 1.00 MAPT (0.85) MAPTKMT2ANPSR1MEN1KCNA3
Cardamomin SCHEMBL30891551 0.92 MAPT (1.00) MAPTKMT2ANPSR1MEN1KCNA3
Cardamomin SCHEMBL1939236 0.92 MAPT (1.00) MAPTKMT2ANPSR1MEN1KCNA3
Cardamomin SCHEMBL25194293 0.92 MAPT (1.00) MAPTKMT2ANPSR1MEN1KCNA3
Cardamomin SCHEMBL449220 0.92 MAPT (1.00) MAPTKMT2ANPSR1MEN1KCNA3
SCHEMBL25203549 0.85 MAPT (0.86) MAPTKMT2ANPSR1MEN1KCNA3
SCHEMBL25203552 0.85 MAPT (0.86) MAPTKMT2ANPSR1MEN1KCNA3
Flavokawain B SCHEMBL25185055 0.83 MAPT (1.00) MAPTKMT2ANPSR1MEN1KCNA3
Flavokawain B SCHEMBL1675987 0.83 MAPT (1.00) MAPTKMT2ANPSR1MEN1KCNA3
Flavokawain B SCHEMBL29439356 0.83 MAPT (1.00) MAPTKMT2ANPSR1MEN1KCNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9061984-B2 Compounds related to chalcones and benzothienopyrimidines, their synthesis, and uses to treat diseases UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2015-06-23 US disclosed
US-20110190325-A1 COMPOUNDS, THEIR SYNTHESES, AND THIER USES THE JOHNS HOPKINS UNIVERSITY 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190325-A1 COMPOUNDS, THEIR SYNTHESES, AND THIER USES TERT, TYMS, NISCH MAPT 2194/4885KMT2A 1587/4885NPSR1 2710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.